Teasing out the link between moderation in health spending and subpar economic growth is a daunting but important task that could have a big and unpredictable impact on the American economy in the years and decades ahead. Continue reading Hard to Split Cloud, Silver Lining→
If the good news we’ve been hearing about American health costs in the past few months turns out to be the new norm – it’s too early to tell – then much of today’s political debate is wildly misguided. Consultants predict 2014 will see abnormally low inflation, again. Medicare spending per beneficiary is dropping more than previously anticipated. And new tools provided by Obamacare to constrain costs could accelerate these trends. Continue reading So What’s the Problem?→
There are two interesting additions to the annals of political influence which focus on quiet issue lobbying.
The quiet lobbying game works best when no one looks carefully at the sausage-making machinery. It offers a stark contrast to the money game where contributors present themselves as 800-lb gorillas who are willing to spend as much as it takes to make things happen their way. Continue reading Lobbying’s Hidden Persuaders→
Is it wise policy to encourage Americans who already spend more than $8 billion annually on these tests to get more? And why does Obamacare, which generally favors evidence-based medicine, mandate this service despite new research suggesting mammograms don’t save lives.